Cochrane Abstracts
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Treatment Regimens for Administration of Anti‐vascular Endothelial Growth Factor Agents for Neovascular Age‐related Macular Degeneration New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New. Accessed 21 September 2020.
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New. Accessed September 21, 2020.
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New. In Cochrane Abstracts Retrieved September 21, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New
Treatment Regimens for Administration of Anti‐vascular Endothelial Growth Factor Agents for Neovascular Age‐related Macular Degeneration New [Internet]. In: Cochrane Abstracts. [cited 2020 September 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New
ID - 439536
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New
DB - Evidence Central
DP - Unbound Medicine
ER -
